Literature DB >> 28760331

The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.

Daisuke Sano1, Kenichiro Yabuki2, Yasuhiro Arai2, Teruhiko Tanabe2, Yoshihiro Chiba2, Goshi Nishimura2, Hideaki Takahashi2, Shoji Yamanaka3, Nobuhiko Oridate2.   

Abstract

OBJECTIVE: The purpose of this study is to validate the applicability of new TNM classification for human papillomavirus (HPV)-related oropharyngeal cancer (OPC) in the 8th edition of the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) TNM staging system in Japan.
METHODS: A total of 91 OPC patients treated with radiation-based therapy between November 2001 and July 2015 were analyzed retrospectively in this study. HPV infection status was evaluated using tumor p16 expression.
RESULTS: 40 OPC patients (44.0%) had HPV-positive disease in this study. The distribution of disease stage of HPV-positive OPC patients dramatically changed from the 7th edition to the 8th edition of AJCC/UICC TNM classification. However, neither the 8th edition nor the 7th edition of the AJCC/UICC TNM staging system could adequately predict outcomes of HPV-positive OPC patients in our patient series. On the other hand, our multivariate analysis indicated that matted nodes and age ≥63 were independent prognostic factors for progression-free survival. In addition, HPV-positive OPC patients with stage I without matted nodes showed significantly better overall and progression-free survival compared with those with stage I with matted nodes and stages II and III in the 8th edition of the AJCC/UICC TNM staging system (P=0.008, and P=0.043, respectively).
CONCLUSION: Our results suggested that matted nodes of HPV-positive OPC patients might be additionally examined to apply the 8th edition of AJCC/UICC TNM classification for more adequate predicting outcomes of HPV-positive OPC patients.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HPV-positive OPC; Matted nodes; The 8th edition of the AJCC/UICC TNM classification

Mesh:

Year:  2017        PMID: 28760331     DOI: 10.1016/j.anl.2017.07.010

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  6 in total

1.  Validation and assessment of discordance of the 8th edition AJCC (American Joint Committee on Cancer) clinical and pathologic staging systems in patients with p16+ oropharyngeal cancer treated with surgery and adjuvant radiation at a single institution.

Authors:  Piyush Gupta; Jocelyn C Migliacci; Ashley Hay; Matthew Rosenthal; Ximena Mimica; Nancy Lee; Richard J Wong; Jatin Shah; Snehal Patel; Ian Ganly
Journal:  Oral Oncol       Date:  2018-06-23       Impact factor: 5.337

2.  Peak of Standardized Uptake Value in Oral Cancer Predicts Survival Adjusting for Pathological Stage.

Authors:  Hidenori Suzuki; Tsuneo Tamaki; Masami Nishio; Shintaro Beppu; Nobuaki Mukoyama; Nobuhiro Hanai; Daisuke Nishikawa; Yusuke Koide; Yasuhisa Hasegawa
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

3.  Refining prognostic stratification of human papillomavirus-related oropharyngeal squamous cell carcinoma: different prognosis between T1 and T2.

Authors:  Sumin Lee; Sang-Wook Lee; Sunmin Park; Sang Min Yoon; Jin-Hong Park; Si Yeol Song; Seung Do Ahn; Jong Hoon Kim; Eun Kyung Choi; Su Ssan Kim; Jinhong Jung; Young Seok Kim
Journal:  Radiat Oncol J       Date:  2017-09-29

4.  Value of transoral surgery for human papillomavirus-mediated oropharyngeal cancer: validation of a new staging system in Japanese patients.

Authors:  Eiko Kimura; Koji Araki; Masayuki Tomifuji; Yuya Tanaka; Kosuke Uno; Taku Yamashita; Akihiro Shiotani
Journal:  J Int Med Res       Date:  2019-09-13       Impact factor: 1.671

5.  Positive Rate of Human Papillomavirus and Its Trend in Head and Neck Cancer in South Korea.

Authors:  Hyun Woong Jun; Yong Bae Ji; Chang Myeon Song; Jae Kyung Myung; Hae Jin Park; Kyung Tae
Journal:  Front Surg       Date:  2022-01-21

6.  Pretreatment prognostic factor for patients with human papillomavirus related oropharyngeal cancer.

Authors:  Daisuke Sano; Nobuhiko Oridate
Journal:  Transl Cancer Res       Date:  2019-04       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.